Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers

Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers

US Patent 8466130 · Granted Jun 18, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting redox-active pyridinium cations to mitochondria to inhibit proliferati2025
Mito-honokiol compounds and methods of synthesis and use thereof2024
Mito-magnolol compounds and methods of synthesis and use thereof2023
Mito-lonidamine, compositions and methods of use2022
Mito-magnolol compounds and methods of synthesis and use thereof2021
Mito-honokiol compounds and methods of synthesis and use thereof2020
Neuroprotection by mitochondria-targeted metformin2020
Neuroprotection by mitochondria-targeted metformin2018
Androgen induced oxidative stress inhibitors2015
Androgen induced oxidative stress inhibitors2015
Neuroprotective compounds and their use2015
Neuroprotective compounds and their use2015